"Tocilizumab Mitigates the Risk of Severe Cytokine Release Syndrome in " by Amir Toor MD and Usama Gergis MD, MBA
 

Tocilizumab Mitigates the Risk of Severe Cytokine Release Syndrome in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

Publication/Presentation Date

2-2025

Volume

31

Issue

2

First Page

156

Last Page

157

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Lehigh Valley Topper Cancer Institute

Document Type

Article

Share

COinS